Anti-Trypanosoma cruzi Potential of New Pyrazole-Imidazoline Derivatives
Molecules · 2025
DOI: 10.3390/molecules30153082 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Edinaldo Castro de Oliveira und 10 weiteren Autor:innen. Beteiligte Einrichtung: Laboratório de Ultraestrutura Celular, Instituto Oswaldo Cruz, Fiocruz, Av. Brasil 4365 Manguinhos, Rio de Janeiro 21040-900, RJ, Brazil. Hauptthemen laut MEDLINE: Trypanosoma cruzi, Pyrazoles, Trypanocidal Agents, Imidazolines. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Council for Scientific and Technological Development, Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro, Fundação de Amparo à Pesquisa do Estado de Minas Gerais.
Abstract (Originalsprache)
Chagas disease, caused by Trypanosoma cruzi, poses a significant public health challenge due to its widespread prevalence, limited therapeutic options, and adverse effects associated with available medications. In this study, we developed 13 novel pyrazole-imidazoline derivatives, inspired by a previously identified cysteine protease inhibitor, and evaluated their antiparasitic activity. Our in silico analyses predicted favorable physicochemical profiles and promising oral bioavailability for these derivatives. Upon phenotypic screening, we observed that these new derivatives exhibited low cytotoxicity (CC50 > 100 µM) and marked efficacy against intracellular amastigotes. Derivative 1k showed high activity (IC50 = 3.3 ± 0.2 µM), selectivity (SI = 73.9), and potency (pIC50 = 5.4). In a 3D cardiac microtissue model, 1k significantly reduced parasite load, matching the efficacy of benznidazole (Bz) even at lower concentrations. Both 1k and Bz effectively prevented parasite recrudescence; however, neither resulted in parasite sterility under the experimental conditions employed. The combination of 1k–Bz yielded an additive interaction, highlighting its potential for in vivo combination therapy. While structural changes abolished cysteine protease inhibition, incorporating a CF3 substituent at the para position and excluding the amino group enhanced antiparasitic activity. These findings reinforce the promise of the pyrazole-imidazoline scaffold and support further structural optimizations to develop innovative candidates for treating Chagas disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratório de Ultraestrutura Celular, Instituto Oswaldo Cruz, Fiocruz, Av. Brasil 4365 Manguinhos, Rio de Janeiro 21040-900, RJ, Brazil.
- Laboratório de Síntese de Sistemas Heterocíclicos (LaSSH), Instituto de Física e Química (IFQ), Universidade Federal de Itajubá, Avenida BPS, 1303, Pinheirinho, Itajubá, Minas Gerais 37500-903, MG, Brazil.
ORCID-Profile: Edinaldo Castro de Oliveira, Leonardo da Silva Lara, Lorraine Martins Rocha Orlando, Maurício Silva Dos Santos, Mirian Claudia de Souza Pereira
Förderung
- National Council for Scientific and Technological Development
- Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
- Fundação de Amparo à Pesquisa do Estado de Minas Gerais
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
- Fundação Oswaldo Cruz, Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ)
- Fundação Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Physics and Chemistry Institute-UNIFEI
Zitieren
APA
de Oliveira, E. C., Lara, L. D. S., Orlando, L. M. R., Lanera, S. D. C., de Souza, T. P., Figueiredo, N. D. S., Paes, V. B., Mazzochi, A. C., Fernandes, P. H. M., Dos Santos, M. S., & Pereira, M. C. S. (2025). Anti-Trypanosoma cruzi Potential of New Pyrazole-Imidazoline Derivatives. Molecules. https://doi.org/10.3390/molecules30153082
Vancouver
de Oliveira EC, Lara LDS, Orlando LMR, Lanera SDC, de Souza TP, Figueiredo NDS, et al. Anti-Trypanosoma cruzi Potential of New Pyrazole-Imidazoline Derivatives. Molecules. 2025. doi:10.3390/molecules30153082
BibTeX
@article{deOliveira2025,
author = {de Oliveira, Edinaldo Castro and Lara, Leonardo da Silva and Orlando, Lorraine Martins Rocha and Lanera, Sarah da Costa and de Souza, Thamyris Perez and Figueiredo, Nathalia da Silva and Paes, Vitoria Barbosa and Mazzochi, Ana Carolina and Fernandes, Pedro Henrique Myra and Dos Santos, Maurício Silva and Pereira, Mirian Claudia de Souza},
title = {Anti-Trypanosoma cruzi Potential of New Pyrazole-Imidazoline Derivatives},
journal = {Molecules},
year = {2025},
doi = {10.3390/molecules30153082}
}
EUVIMED